Cargando…
Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter
Malaria remains a major international health challenge. Resistance to a number of existing drugs and evidence of the emergence of artemisinin resistance has emphasized the need for new antimalarials. A new approach has been the preparation of dual-function compounds that include a chloroquine-like a...
Autores principales: | Egan, Timothy J, Kuter, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099626/ https://www.ncbi.nlm.nih.gov/pubmed/23534360 http://dx.doi.org/10.2217/fmb.13.18 |
Ejemplares similares
-
Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains
por: Lawrenson, Alexandre S., et al.
Publicado: (2018) -
A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine
por: Kucharski, Dawid J., et al.
Publicado: (2022) -
Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010) -
Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance
por: Warhurst, David C., et al.
Publicado: (2016) -
Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)